New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
06:01 EDTNVAXNovavax price target raised to $9 from $7 at Piper Jaffray
Piper Jaffray raised its price target for Novavax shares to $9 and says the stock remains a top pick for 2014. Piper believes the company's RSV vaccine in development is a potential blockbuster and reiterates an Overweight rating in the stock.
News For NVAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for NVAX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use